U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Product Type (Directional Atherectomy Systems, Orbital Atherectomy Systems), By Application, By End Use, And Segment Forecasts, 2024 - 2030

U.S. Atherectomy Devices Market Size, Share & Trends Analysis Report By Product Type (Directional Atherectomy Systems, Orbital Atherectomy Systems), By Application, By End Use, And Segment Forecasts, 2024 - 2030

U.S. Atherectomy Devices Market Growth & Trends

The U.S. atherectomy devices market size is expected to reach USD 938.7 million by 2030, expanding at a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The regional market is expected to witness lucrative growth due to the rising prevalence of target diseases and preference for endovascular procedures. Moreover, rising demand for minimally invasive procedure will boost the market growth. Such procedures are less painful and allow quicker recovery than invasive procedures.

Other advantages, such as higher patient satisfaction owing to fewer incision wounds, few post-surgical complications, and low mortality rates, are also driving the atherectomy devices market growth. Technological advancements allowing early diagnosis are also likely to augment the market growth in the near future. For instance, in January 2017, Medtronic received CE mark approval for HawkOne directional atherectomy system for treating patients suffering from Peripheral Artery Disease (PAD).

U.S. Atherectomy Devices Market Report Highlights

• Directional atherectomy systems dominated the market and accounted for a share of 37.2% in 2023.
• Office-Based Labs (OBLs) is anticipated to be the fastest-growing segment in the forecast period due to a greater number of Peripheral Vascular Interventional (PVI) procedures being performed in this setting
• In addition, lesser number of complications and follow-up procedures lowers the cost and increases the adoption of new technologies delivering better health outcomes, which is anticipated to propel the market growth in the coming years
• Several ongoing trials and their positive results facilitate penetration of novel technologies. For instance, Abbott acquired the medical device company Cardiovascular Systems, Inc. (CSI) in April 2023 to enhance its capabilities to treat patients with peripheral and coronary diseases.
• Some of the key companies are Abbott; Boston Scientific Corp.;B. Braun SE; AngioDynamics; Terumo Medical Corp.; Cardiovascular Systems, Inc.; Medtronic PLC; Avinger, Inc.; ST. JUDE MEDICAL, Inc.

Please note The report will be delivered in 4-8 business days upon order notification.